Biohaven (BHVN) Other Non Operating Income (2021 - 2024)
Biohaven (BHVN) posted Other Non Operating Income of $4.3 million for Q1 2024, down 44.4% sequentially from $7.7 million in Q4 2023, and down 47.69% YoY from $8.2 million in Q2 2023.
Biohaven (BHVN) Other Non Operating Income (2021 - 2024) Analysis & Trends
Biohaven has reported Other Non Operating Income for 4 years, with the latest figure at $4.3 million in Q1 2024.
- Quarterly Other Non Operating Income fell 47.69% year-over-year to $4.3 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $22.6 million (up 256.99% YoY) and the FY2025 annual result came in at $8.0 million, down 79.71% from the prior year.
- Other Non Operating Income slipped to $4.3 million in Q1 2024 per BHVN's latest filing, from $7.7 million in the prior quarter.
- Over five years, Other Non Operating Income peaked at $8.2 million in Q1 2023 and troughed at -$1.8 million in Q4 2022.
- A 4-year average of $3.0 million and a median of $2.9 million in 2021 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2022 and 2023: Other Non Operating Income sank 226.41% in 2022, then surged 205825.0% in 2023.
- Over 4 years, Other Non Operating Income stood at $1.5 million in 2021, then tumbled by 226.41% to -$1.8 million in 2022, then surged by 521.27% to $7.7 million in 2023, then sank by 44.4% to $4.3 million in 2024.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $4.3 million, $7.7 million, and $4.7 million for Q1 2024, Q4 2023, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Biohaven | 2.21 Bn | 1.94 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 4.31 Mn |
| Dec 31, 2023 | 7.74 Mn |
| Sep 30, 2023 | 4.69 Mn |
| Jun 30, 2023 | 5.84 Mn |
| Mar 31, 2023 | 8.23 Mn |
| Dec 31, 2022 | -1.84 Mn |
| Jun 30, 2022 | -67,000.00 |
| Mar 31, 2022 | -4,000.00 |
| Dec 31, 2021 | 1.45 Mn |
| Sep 30, 2021 | -5,000.00 |